Cargando…

Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems

PURPOSE: To describe and validate the dose calculation algorithm of an independent second-dose check software for spot scanning proton delivery systems with full width at half maximum between 5 and 14 mm and with a negligible spray component. METHODS: The analytical dose engine of our independent se...

Descripción completa

Detalles Bibliográficos
Autores principales: Younkin, James E., Morales, Danairis Hernandez, Shen, Jiajian, Shan, Jie, Bues, Martin, Lentz, Jarrod M., Schild, Steven E., Stoker, Joshua B., Ding, Xiaoning, Liu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876166/
https://www.ncbi.nlm.nih.gov/pubmed/31755362
http://dx.doi.org/10.1177/1533033819887182
_version_ 1783473167051784192
author Younkin, James E.
Morales, Danairis Hernandez
Shen, Jiajian
Shan, Jie
Bues, Martin
Lentz, Jarrod M.
Schild, Steven E.
Stoker, Joshua B.
Ding, Xiaoning
Liu, Wei
author_facet Younkin, James E.
Morales, Danairis Hernandez
Shen, Jiajian
Shan, Jie
Bues, Martin
Lentz, Jarrod M.
Schild, Steven E.
Stoker, Joshua B.
Ding, Xiaoning
Liu, Wei
author_sort Younkin, James E.
collection PubMed
description PURPOSE: To describe and validate the dose calculation algorithm of an independent second-dose check software for spot scanning proton delivery systems with full width at half maximum between 5 and 14 mm and with a negligible spray component. METHODS: The analytical dose engine of our independent second-dose check software employs an altered pencil beam algorithm with 3 lateral Gaussian components. It was commissioned using Geant4 and validated by comparison to point dose measurements at several depths within spread-out Bragg peaks of varying ranges, modulations, and field sizes. Water equivalent distance was used to compensate for inhomogeneous geometry. Twelve patients representing different disease sites were selected for validation. Dose calculation results in water were compared to a fast Monte Carlo code and ionization chamber array measurements using dose planes and dose profiles as well as 2-dimensional–3-dimensional and 3-dimensional–3-dimensional γ-index analysis. Results in patient geometry were compared to Monte Carlo simulation using dose–volume histogram indices, 3-dimensional–3-dimensional γ-index analysis, and inpatient dose profiles. RESULTS: Dose engine model parameters were tuned to achieve 1.5% agreement with measured point doses. The in-water γ-index passing rates for the 12 patients using 3%/2 mm criteria were 99.5% ± 0.5% compared to Monte Carlo. The average inpatient γ-index analysis passing rate compared to Monte Carlo was 95.8% ± 2.9%. The average difference in mean dose to the clinical target volume between the dose engine and Monte Carlo was −0.4% ± 1.0%. For a typical plan, dose calculation time was 2 minutes on an inexpensive workstation. CONCLUSIONS: Following our commissioning process, the analytical dose engine was validated for all treatment sites except for the lung or for calculating dose–volume histogram indices involving point doses or critical structures immediately distal to target volumes. Monte Carlo simulations are recommended for these scenarios.
format Online
Article
Text
id pubmed-6876166
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-68761662019-12-04 Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems Younkin, James E. Morales, Danairis Hernandez Shen, Jiajian Shan, Jie Bues, Martin Lentz, Jarrod M. Schild, Steven E. Stoker, Joshua B. Ding, Xiaoning Liu, Wei Technol Cancer Res Treat Original Article PURPOSE: To describe and validate the dose calculation algorithm of an independent second-dose check software for spot scanning proton delivery systems with full width at half maximum between 5 and 14 mm and with a negligible spray component. METHODS: The analytical dose engine of our independent second-dose check software employs an altered pencil beam algorithm with 3 lateral Gaussian components. It was commissioned using Geant4 and validated by comparison to point dose measurements at several depths within spread-out Bragg peaks of varying ranges, modulations, and field sizes. Water equivalent distance was used to compensate for inhomogeneous geometry. Twelve patients representing different disease sites were selected for validation. Dose calculation results in water were compared to a fast Monte Carlo code and ionization chamber array measurements using dose planes and dose profiles as well as 2-dimensional–3-dimensional and 3-dimensional–3-dimensional γ-index analysis. Results in patient geometry were compared to Monte Carlo simulation using dose–volume histogram indices, 3-dimensional–3-dimensional γ-index analysis, and inpatient dose profiles. RESULTS: Dose engine model parameters were tuned to achieve 1.5% agreement with measured point doses. The in-water γ-index passing rates for the 12 patients using 3%/2 mm criteria were 99.5% ± 0.5% compared to Monte Carlo. The average inpatient γ-index analysis passing rate compared to Monte Carlo was 95.8% ± 2.9%. The average difference in mean dose to the clinical target volume between the dose engine and Monte Carlo was −0.4% ± 1.0%. For a typical plan, dose calculation time was 2 minutes on an inexpensive workstation. CONCLUSIONS: Following our commissioning process, the analytical dose engine was validated for all treatment sites except for the lung or for calculating dose–volume histogram indices involving point doses or critical structures immediately distal to target volumes. Monte Carlo simulations are recommended for these scenarios. SAGE Publications 2019-11-22 /pmc/articles/PMC6876166/ /pubmed/31755362 http://dx.doi.org/10.1177/1533033819887182 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Younkin, James E.
Morales, Danairis Hernandez
Shen, Jiajian
Shan, Jie
Bues, Martin
Lentz, Jarrod M.
Schild, Steven E.
Stoker, Joshua B.
Ding, Xiaoning
Liu, Wei
Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title_full Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title_fullStr Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title_full_unstemmed Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title_short Clinical Validation of a Ray-Casting Analytical Dose Engine for Spot Scanning Proton Delivery Systems
title_sort clinical validation of a ray-casting analytical dose engine for spot scanning proton delivery systems
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876166/
https://www.ncbi.nlm.nih.gov/pubmed/31755362
http://dx.doi.org/10.1177/1533033819887182
work_keys_str_mv AT younkinjamese clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT moralesdanairishernandez clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT shenjiajian clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT shanjie clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT buesmartin clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT lentzjarrodm clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT schildstevene clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT stokerjoshuab clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT dingxiaoning clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems
AT liuwei clinicalvalidationofaraycastinganalyticaldoseengineforspotscanningprotondeliverysystems